KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Total Non-Current Liabilities (2018 - 2025)

Historic Total Non-Current Liabilities for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to $181.2 million.

  • Twist Bioscience's Total Non-Current Liabilities rose 1906.1% to $181.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $181.2 million, marking a year-over-year increase of 1906.1%. This contributed to the annual value of $168.2 million for FY2025, which is 1906.79% up from last year.
  • Latest data reveals that Twist Bioscience reported Total Non-Current Liabilities of $181.2 million as of Q4 2025, which was up 1906.1% from $168.2 million recorded in Q3 2025.
  • In the past 5 years, Twist Bioscience's Total Non-Current Liabilities ranged from a high of $181.2 million in Q4 2025 and a low of -$22.4 million during Q4 2021
  • Its 5-year average for Total Non-Current Liabilities is $137.5 million, with a median of $151.2 million in 2022.
  • In the last 5 years, Twist Bioscience's Total Non-Current Liabilities plummeted by 13642.52% in 2021 and then surged by 83133.49% in 2022.
  • Twist Bioscience's Total Non-Current Liabilities (Quarter) stood at -$22.4 million in 2021, then surged by 831.33% to $163.6 million in 2022, then decreased by 13.01% to $142.3 million in 2023, then grew by 6.98% to $152.2 million in 2024, then increased by 19.06% to $181.2 million in 2025.
  • Its Total Non-Current Liabilities was $181.2 million in Q4 2025, compared to $168.2 million in Q3 2025 and $164.7 million in Q2 2025.